Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulator for Postpartum Depression
Study Summary
This trial will help to establish whether or not rTMS is an effective treatment for peripartum depression.
- Postpartum Depression
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a stroke in the past.You have metal objects inside your head, except for dental hardware.You have tried electroconvulsive therapy (ECT) during this episode of illness and it did not work. Previous ECT treatments from previous episodes do not affect your eligibility.You have been taking lorazepam at a dose of 2 mg or more per day in the past four weeks.You have a serious brain or neurological condition, like epilepsy, multiple sclerosis, or a brain tumor that could affect the study.Women who are currently going through post-birth depression as determined by a special interview.You don't want to take medication for depression, or you have tried medication and therapy but your depression hasn't gotten better.You are currently taking lorazepam (or a similar medication) at a high dose (greater than 2 mg per day) within the past 4 weeks. This can affect the effectiveness of the treatment being studied.You have a history of epilepsy, seizures, or pre-eclampsia (a condition that can occur during pregnancy).You currently have a problem with alcohol and may be dependent on it.You have a history of mental illness that includes losing touch with reality or having hallucinations.You have been diagnosed with bipolar disorder.You are currently having thoughts about hurting yourself.You have tried rTMS treatment before, but it didn't work for you.
- Group 1: Open label iTBS rTMS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any opportunities to join this experiment?
"Affirmative. Information on clinicaltrials.gov suggests that this medical study is currently seeking participants, which began advertising on December 1st 2022 and was most recently updated November 9th of the same year. A total of 30 patients are needed to be recruited from one location."
Is the patient demographic for this clinical trial limited to those under 50 years old?
"As per the guidelines of this medical trial, potential participants must be aged 18 to 40."
What qualifications are necessary for someone to be eligible for this research trial?
"This medical trial seeks 30 participants with postpartum depression aged 18 to 40. To qualify for the study, subjects must have a current MINI-International Neuropsychiatric Interview diagnosis of peripartum depression and exhibit moderate severity as indicated by an Edinburgh Postnatal Depression Scale score of 15 or greater (antepartum) or 12 or more (postpartum). Additional eligibility requirements include being pregnant within one month post childbirth, refraining from antidepressant therapy/not responding to psychotropic drugs or talk therapies, agreeing to remain on a stable medication plan throughout the study's duration, and falling between 18 and 40 years old."
What is the sample size for this clinical exploration?
"Affirmative, the clinical trial is still searching for participants. The initial listing was posted on December 1st 2022 and has since been updated as of November 9th 2022. There are 30 slots available at a single site."
Share this study with friends
Copy Link
Messenger